Disease. In 33 of these cases, it was possible to undertake a complete evaluation of the cardio-digestive tract, which, according to the criteria used in endemic areas, enabled us to establish that these patients can also be considered with the indeterminate form of the disease. However, critical changes evaluation to special forms of this disease may be evident only after 15 years or longer [22]. ?In Bambui (Minas Gerais State, Brazil), 40 of chagasic patients evaluated after the acute phase remained with the indeterminate form for 40 years [1]. In Pains and Iguatama (Minas Gerais), Coura et al. (1985) conducted a longitudinal study of patients with the indeterminate form who were free of early heart disease and found that after 10 years, 57773-65-6 chemical information chronic heart disease developed in 38.3 of patients [23]. We found five of those treated patients with established cardiac chronic form of the disease. We assume that the delay in treatment contributed to this result. However, a more aggressive acute phase in four of those five patients seems to have played a decisive role in ?this outcome. In Bambui, there was a correlation between progression to chronic heart disease and electrocardiographic changes during the acute phase in patients that were reexamined after 30 years [1]. Autochthonous determinate form of chronic Chagas disease in Amazon has only been reported just in two registers, one of chagasic megacolon [24] and other of dilated cardiomyopathy [25,26]. These studies indicate an exceptional profile of chronic disease in the region, although such cases have been described since 1969. However, the prevalence rates for chronic phase of the disease in Amazon are nonexistent. Given the technical difficulties of monitoring and providing diagnostic evidence of a cure in treated patients, we also HIV-RT inhibitor 1 biological activity applied molecular techniques to search for T. cruzi antigens in those patients treated for more than two years and six had positive results for T. cruzi I. All were seropositive, with low IgG antibody titers. As a technique for assessing treatment success, PCR has shown promising results. In Bolivia, a study 113 children with positive serology or positive QBC and found that 106 of them were also positive by PCR (sensitivity 93.8 ). Among the seronegative controls, one positive PCR was detected, but this was attributed topossible sample contamination. Wincker et al. (1994) and Britto et al. (1995) demonstrated 90 sensitivity of this technique and suggested that PCR is an effective tool to evaluate cure rates, providing a useful adjunct to serological tests [13,27]. In our study, the proportion of therapeutic failures observed using xenodiagnosis was 2.3 . By blood culture, this failure rate was 3.5 , rising to 9.8 among individuals tested by PCR. Furthermore, positive results detected by these three techniques occurred during different periods after treatment. Failures detected by xenodiagnosis and blood culture were only detected immediately post-treatment, except for one case that was detected after ten years, in which there was a reactivation of Chagas disease due to acute HIV infection (unpublished data). For PCR assays, failures 23977191 were demonstrated later, with the acute phase varying between 2 and 6 years prior to PCR testing, which suggest that this technique maybe is more sensitive for the evaluation of cure rates. Galvao et al. (2003) demonstrated that PCR was 1.6 times more sensitive than serological techniques for detecting therapeutic failures i.Disease. In 33 of these cases, it was possible to undertake a complete evaluation of the cardio-digestive tract, which, according to the criteria used in endemic areas, enabled us to establish that these patients can also be considered with the indeterminate form of the disease. However, critical changes evaluation to special forms of this disease may be evident only after 15 years or longer [22]. ?In Bambui (Minas Gerais State, Brazil), 40 of chagasic patients evaluated after the acute phase remained with the indeterminate form for 40 years [1]. In Pains and Iguatama (Minas Gerais), Coura et al. (1985) conducted a longitudinal study of patients with the indeterminate form who were free of early heart disease and found that after 10 years, chronic heart disease developed in 38.3 of patients [23]. We found five of those treated patients with established cardiac chronic form of the disease. We assume that the delay in treatment contributed to this result. However, a more aggressive acute phase in four of those five patients seems to have played a decisive role in ?this outcome. In Bambui, there was a correlation between progression to chronic heart disease and electrocardiographic changes during the acute phase in patients that were reexamined after 30 years [1]. Autochthonous determinate form of chronic Chagas disease in Amazon has only been reported just in two registers, one of chagasic megacolon [24] and other of dilated cardiomyopathy [25,26]. These studies indicate an exceptional profile of chronic disease in the region, although such cases have been described since 1969. However, the prevalence rates for chronic phase of the disease in Amazon are nonexistent. Given the technical difficulties of monitoring and providing diagnostic evidence of a cure in treated patients, we also applied molecular techniques to search for T. cruzi antigens in those patients treated for more than two years and six had positive results for T. cruzi I. All were seropositive, with low IgG antibody titers. As a technique for assessing treatment success, PCR has shown promising results. In Bolivia, a study 113 children with positive serology or positive QBC and found that 106 of them were also positive by PCR (sensitivity 93.8 ). Among the seronegative controls, one positive PCR was detected, but this was attributed topossible sample contamination. Wincker et al. (1994) and Britto et al. (1995) demonstrated 90 sensitivity of this technique and suggested that PCR is an effective tool to evaluate cure rates, providing a useful adjunct to serological tests [13,27]. In our study, the proportion of therapeutic failures observed using xenodiagnosis was 2.3 . By blood culture, this failure rate was 3.5 , rising to 9.8 among individuals tested by PCR. Furthermore, positive results detected by these three techniques occurred during different periods after treatment. Failures detected by xenodiagnosis and blood culture were only detected immediately post-treatment, except for one case that was detected after ten years, in which there was a reactivation of Chagas disease due to acute HIV infection (unpublished data). For PCR assays, failures 23977191 were demonstrated later, with the acute phase varying between 2 and 6 years prior to PCR testing, which suggest that this technique maybe is more sensitive for the evaluation of cure rates. Galvao et al. (2003) demonstrated that PCR was 1.6 times more sensitive than serological techniques for detecting therapeutic failures i.
